Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Naproxen with Low Dose ASA for Gastroduodenal Ulcers
NCT00137033Phase 4Completed
- Sponsor
- Viatris
- Start
- Sep 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in osteoarthritis (OA) and rheumatoid arthritis (RA) (3 arms), sponsored by Viatris. Primary endpoint: Incidence of gastroduodenal endoscopic ulcers at 7 days. Started Sep 2004; status: completed.
02
Drugs
celecoxib
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00137033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137033.